Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon

Pharm Dev Technol. 2024 Mar;29(3):212-220. doi: 10.1080/10837450.2024.2321250. Epub 2024 Mar 6.

Abstract

The current budesonide formulations are inadequate for addressing left-sided colitis, and patients might hesitate to use an enema for a prolonged time. This study focuses on developing a single-layer coating for budesonide pellets targeting the descending colon. Pellets containing budesonide (1.5%w/w), PVP K30 (5%w/w), lactose monohydrate (25%w/w) and Avicel pH 102 (68.5%w/w) were prepared using extrusion spheronization technique. Coating formulations were designed using response surface methodology with pH and time-dependent Eudragits. Dissolution tests were conducted at different pH levels (1.2, 6.5, 6.8, and 7.2). Optimal coating formulation, considering coating level and the Eudragit (S + L) ratio to the total coating weight, was determined. Budesonide pellets were coated with the optimized composition and subjected to continuous dissolution testing simulating the gastrointestinal tract. The coating, with 48% S, 12% L, and 40% RS at a 10% coating level, demonstrated superior budesonide delivery to the descending colon. Coated pellets had a spherical shape with a uniform 30 µm thickness coating, exhibiting pH and time-dependent release. Notably, zero-order release kinetics was observed for the last 9 h in colonic conditions. The study suggests that an optimized single-layer coating, incorporating pH and time-dependent polymers, holds promise for consistently delivering budesonide to the descending colon.

Keywords: Budesonide pellets; descending colon; pH-dependent; targeted delivery; time-dependent.

MeSH terms

  • Budesonide*
  • Colon
  • Colon, Descending
  • Drug Delivery Systems*
  • Drug Implants
  • Humans
  • Polymethacrylic Acids*
  • Solubility

Substances

  • Budesonide
  • methylmethacrylate-methacrylic acid copolymer
  • Drug Implants
  • Polymethacrylic Acids